PDCD1 and melanoma: It is well known that the PD-1/PD-L1 pathway is responsible for cancer immune escape and elevated PD-L1 expression correlates with disease stage and poor prognosis in many cancer types, such as melanoma, breast, ovarian, gastric, liver, kidney, and pancreatic [28].